A Pilot Study to Investigate the Potential of Buparid/PARI SINUS Versus Budes Nasal Spray to Avoid or Postpone Sinus Surgery in Adult Patients With Chronic Rhinosinusitis

Trial Profile

A Pilot Study to Investigate the Potential of Buparid/PARI SINUS Versus Budes Nasal Spray to Avoid or Postpone Sinus Surgery in Adult Patients With Chronic Rhinosinusitis

Recruiting
Phase of Trial: Phase III

Latest Information Update: 13 Apr 2017

At a glance

  • Drugs Budesonide (Primary) ; Budesonide (Primary)
  • Indications Rhinosinusitis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors PARI Pharma GmbH
  • Most Recent Events

    • 12 Dec 2016 Planned End Date changed from 1 May 2017 to 1 May 2018.
    • 12 Dec 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
    • 30 Mar 2016 Planned End Date changed from 1 Nov 2016 to 1 May 2017 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top